Author Correction: Membrane potential drives the exit from pluripotency and cell fate commitment via calcium and mTOR

Author Correction: Membrane potential drives the exit from pluripotency and cell fate commitment via calcium and mTOR

Bibliographic Details
Main Authors:	Emily Sempou, Valentyna Kostiuk, Jie Zhu, M. Cecilia Guerra, Leonid Tyan, Woong Hwang, Elena Camacho-Aguilar, Michael J. Caplan, David Zenisek, Aryeh Warmflash, Nick D. L. Owens, Mustafa K. Khokha
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-06-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-023-39025-z

Similar Items

Membrane potential drives the exit from pluripotency and cell fate commitment via calcium and mTOR
by: Emily Sempou, et al.
Published: (2022-11-01)

The role of tryptophan and the mTOR pathway in T cell fate determination
by: Karydis, I, et al.
Published: (2014)

mTOR links environmental signals to T cell fate decisions
by: Nicole M Chapman, et al.
Published: (2015-01-01)

Dissecting the dynamics of signaling events in the BMP, WNT, and NODAL cascade during self-organized fate patterning in human gastruloids.
by: Sapna Chhabra, et al.
Published: (2019-10-01)

Mammalian Target of Rapamycin (mTOR) Signaling at the Crossroad of Muscle Fiber Fate in Sarcopenia
by: Giuseppe Sirago, et al.
Published: (2022-11-01)

The mTOR Pathway in Pluripotent Stem Cells: Lessons for Understanding Cancer Cell Dormancy
by: Bashar A. Alhasan, et al.
Published: (2021-11-01)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
by: Zhilin Zou, et al.
Published: (2020-03-01)

An interplay between extracellular signalling and the dynamics of the exit from pluripotency drives cell fate decisions in mouse ES cells
by: David A. Turner, et al.
Published: (2014-06-01)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
by: Victor H. Villar, et al.
Published: (2017-05-01)

mTOR, autophagy and reprogramming
by: Bor Luen eTang
Published: (2014-01-01)

Exit Strategies and State Building
by: Caplan, R
Published: (1970)

Equine-Induced Pluripotent Stem Cells Retain Lineage Commitment Toward Myogenic and Chondrogenic Fates
by: Mattia Quattrocelli, et al.
Published: (2016-01-01)

Efficient protocol for the differentiation of kidney podocytes from induced pluripotent stem cells, involving the inhibition of mTOR
by: Masahiro Yasuda, et al.
Published: (2023-11-01)

AAA + ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1
by: George K. E. Umanah, et al.
Published: (2022-08-01)

mTOR Signalling, Nutrients and Disease
by: Goberdhan, D, et al.
Published: (2008)

mTOR Signaling: Recent Progress
by: Antonios N. Gargalionis, et al.
Published: (2024-02-01)

The mTOR pathway in the antiphospholipid syndrome
by: Ji Lanlan, et al.
Published: (2023-12-01)

Overview of Research into mTOR Inhibitors
by: Beibei Mao, et al.
Published: (2022-08-01)

mTOR Signaling in Metabolism and Cancer
by: Shile Huang
Published: (2020-10-01)

The Translational Regulation in mTOR Pathway
by: Miaomiao Yang, et al.
Published: (2022-06-01)

Targeting ganglioneuromas with mTOR inhibitors
by: Ting Tao, et al.
Published: (2021-01-01)

mTOR Pathways in Cancer and Autophagy
by: Mathieu Paquette, et al.
Published: (2018-01-01)

Targeting mTOR for cancer therapy
by: Hui Hua, et al.
Published: (2019-07-01)

Whsc1 links pluripotency exit with mesendoderm specification
by: Tian, Tian V., et al.
Published: (2019)

Activated mTOR signaling pathway in myofibers with inherited metabolic defect might be an evidence for mTOR inhibition therapies
by: Jing-Wei Lyu, et al.
Published: (2019-04-01)

All PI3Kinase signaling is not mTOR: Dissecting mTOR-dependent and independent signaling pathways in T cells
by: Christopher Jordan Gamper, et al.
Published: (2012-10-01)

The mTOR pathway and integrating immune regulation.
by: Cobbold, S
Published: (2013)

The effects of mTOR inhibition in ischemic stroke
by: Schneider, AM
Published: (2022)

Advances in the regulatory mechanisms of mTOR in necroptosis
by: Yawen Xie, et al.
Published: (2023-12-01)

Roles of mTOR in Diabetic Kidney Disease
by: Mako Yasuda-Yamahara, et al.
Published: (2021-02-01)

mTOR Signaling in Metabolic Stress Adaptation
by: Cheng-Wei Wu, et al.
Published: (2021-05-01)

Experimental Approaches in Delineating mTOR Signaling
by: Jiayi Qian, et al.
Published: (2020-07-01)

mTOR Signaling Components in Tumor Mechanobiology
by: Antonios N. Gargalionis, et al.
Published: (2022-02-01)

The Role of mTOR and Injury in Developing Salispheres
by: Rimah Saleem, et al.
Published: (2023-02-01)

mTOR Regulation of Metabolism in Hematologic Malignancies
by: Simone Mirabilii, et al.
Published: (2020-02-01)

Expression of mTOR in normal and pathological conditions
by: A Marques-Ramos, et al.
Published: (2023-07-01)

Roles of mTOR Signaling in Tissue Regeneration
by: Xiangyong Wei, et al.
Published: (2019-09-01)

Targeting mTOR in Acute Lymphoblastic Leukemia
by: Carolina Simioni, et al.
Published: (2019-02-01)

An emerging role of mTOR in lipid biosynthesis
by: Laplante, Mathieu, et al.
Published: (2012)

mTOR Signaling in Growth Control and Disease
by: Laplante, Mathieu, et al.
Published: (2014)